[Oncogenic mechanisms of KSHV].
Tomita
Mariko
M
Division of Molecular Virology and Oncology, Department of Microbiology, Graduate School of Medicine, University of the Ryukyus.
Mori
Naoki
N
D000818:Animals; D000956:Antigens, Viral / Q000502:physiology; D017209:Apoptosis / Q000235:genetics; D002453:Cell Cycle / Q000235:genetics; D016207:Cytokines / Q000502:physiology; D019288:Herpesvirus 8, Human / Q000235:genetics*; D006801:Humans; D017874:Immediate-Early Proteins / Q000502:physiology; D009687:Nuclear Proteins / Q000502:physiology; D012514:Sarcoma, Kaposi / Q000276:immunology / Q000821:virology*; D014764:Viral Proteins / Q000502:physiology
D000956:Antigens, Viral; D016207:Cytokines; C118264:HHV8-Vcyc protein, Human herpesvirus 8; D017874:Immediate-Early Proteins; C111600:K1 protein, Human herpesvirus 8; C456022:K3 protein, Kaposi's sarcoma-associated herpesvirus; C405867:K5 protein, Human herpesvirus 8; D009687:Nuclear Proteins; D014764:Viral Proteins; C109540:latency-associated nuclear antigen; C481275:viral FLIP protein, Human herpesvirus 8